Compare PBH & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBH | VIRT |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.9B |
| IPO Year | 2004 | 2014 |
| Metric | PBH | VIRT |
|---|---|---|
| Price | $63.46 | $39.97 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | ★ $80.75 | $42.71 |
| AVG Volume (30 Days) | 358.7K | ★ 910.7K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.38% |
| EPS Growth | 2.88 | ★ 72.73 |
| EPS | 2.78 | ★ 5.13 |
| Revenue | $975,777,000.00 | ★ $3,632,118,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.15 | $4.02 |
| P/E Ratio | $23.33 | ★ $7.88 |
| Revenue Growth | ★ 36.77 | 26.25 |
| 52 Week Low | $57.25 | $31.55 |
| 52 Week High | $88.55 | $45.77 |
| Indicator | PBH | VIRT |
|---|---|---|
| Relative Strength Index (RSI) | 34.53 | 49.38 |
| Support Level | $62.84 | $39.47 |
| Resistance Level | $68.51 | $42.90 |
| Average True Range (ATR) | 1.72 | 1.06 |
| MACD | -0.73 | -0.25 |
| Stochastic Oscillator | 2.88 | 15.47 |
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.